sorafenib has been researched along with nvp bvu972 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (nvp bvu972) | Trials (nvp bvu972) | Recent Studies (post-2010) (nvp bvu972) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 11 | 0 | 10 |
| Protein | Taxonomy | sorafenib (IC50) | nvp bvu972 (IC50) |
|---|---|---|---|
| Chain A, Hepatocyte growth factor receptor | Homo sapiens (human) | 0.014 | |
| Hepatocyte growth factor receptor | Homo sapiens (human) | 0.014 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, M; He, J; Jiang, X; Jiang, Y; Li, J; Liu, J; Ouyang, L; Wang, J; Zhang, J; Zhang, S | 1 |
1 review(s) available for sorafenib and nvp bvu972
| Article | Year |
|---|---|
Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Topics: Antineoplastic Agents; Drug Discovery; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Quinazolines; Quinolones; Receptors, Vascular Endothelial Growth Factor; Small Molecule Libraries | 2016 |